PUVA treatment and choroidal malignant melanoma. 1993

G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
Department of Ophthalmology, Cukurova University, Adana, Turkey.

Choroidal malign melanoma showing rapid progression in a boy 17 years old is presented. The patient was under therapy with methoxy psoralen + Ultraviolet A (PUVA)* for psoriasis vulgaris. He had undergone complete ophthalmologic examinations with three-month intervals from the beginning of this therapy. The tumor was detected in the seventh month, rapidly enlarging within the next twenty days, and eventually leading to enucleation. PUVA is known to be a risk factor for cutaneous malign melanoma. However, there is no reported incidence of choroidal malign melanoma in PUVA treated patients. To our knowledge, this is the only case showing the possible role of PUVA therapy as a predisposing factor in the development of uveal malign melanoma.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D002830 Choroid Neoplasms Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi). Choroidal Neoplasms,Choroid Neoplasm,Choroidal Neoplasm,Neoplasm, Choroid,Neoplasm, Choroidal,Neoplasms, Choroid,Neoplasms, Choroidal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
January 1981, Developments in ophthalmology,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
January 1993, Optometry clinics : the official publication of the Prentice Society,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
February 1986, Bulletin des societes d'ophtalmologie de France,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
January 1984, Progress in clinical and biological research,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
November 1983, American journal of ophthalmology,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
April 1982, Journal of clinical ultrasound : JCU,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
June 1998, The British journal of dermatology,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
June 1987, Annals of ophthalmology,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
January 1986, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
G Haciyakupoğlu, and I Varinli, and H R Memişoğlu, and S Varinli, and N Demircan, and G Denli
November 1985, British journal of hospital medicine,
Copied contents to your clipboard!